What is Entera Bio Ltd. Ordinary Shares's Market Cap?

Entera Bio Ltd. Ordinary Shares's Market Cap is $505.6M, based on as-reported figures from SEC (XBRL) filings.

What is Entera Bio Ltd. Ordinary Shares's Enterprise Value?

Entera Bio Ltd. Ordinary Shares's Enterprise Value is $494.3M, based on as-reported figures from SEC (XBRL) filings.

What is Entera Bio Ltd. Ordinary Shares's EV / EBITDA?

Entera Bio Ltd. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Entera Bio Ltd. Ordinary Shares's Revenue (TTM)?

Entera Bio Ltd. Ordinary Shares's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Entera Bio Ltd. Ordinary Shares's Net Income (TTM)?

Entera Bio Ltd. Ordinary Shares's Net Income (TTM) is -$17.0M, based on as-reported figures from SEC (XBRL) filings.

What is Entera Bio Ltd. Ordinary Shares's EBITDA?

Entera Bio Ltd. Ordinary Shares's EBITDA is -$14.4M, based on as-reported figures from SEC (XBRL) filings.

What is Entera Bio Ltd. Ordinary Shares's Diluted EPS (TTM)?

Entera Bio Ltd. Ordinary Shares's Diluted EPS (TTM) is -0.10, based on as-reported figures from SEC (XBRL) filings.

What is Entera Bio Ltd. Ordinary Shares's Net Debt?

Entera Bio Ltd. Ordinary Shares's Net Debt is -$11.3M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Entera Bio Ltd. Ordinary Shares

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001T8ZSW3

2.92▼ 0.10 (-3.31%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 3.02
Day's Range: 2.86 – 3.02
52-Week Range: 0.91 – 4.20
Volume: 256.9K
Avg Volume: 607.9K

Share Statistics

Shares Outstanding
Employees: 22
Exchange: XNAS
Listed: 2018-06-28

Share count as of August 3, 2026

Entera Bio Ltd. Ordinary Shares (ENTX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Entera Bio Ltd. Ordinary Shares (ENTX)

What is Entera Bio Ltd. Ordinary Shares's Market Cap?: Entera Bio Ltd. Ordinary Shares's Market Cap is $505.6M, based on as-reported figures from SEC (XBRL) filings.
What is Entera Bio Ltd. Ordinary Shares's Enterprise Value?: Entera Bio Ltd. Ordinary Shares's Enterprise Value is $494.3M, based on as-reported figures from SEC (XBRL) filings.
What is Entera Bio Ltd. Ordinary Shares's EV / EBITDA?: Entera Bio Ltd. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Entera Bio Ltd. Ordinary Shares's Revenue (TTM)?: Entera Bio Ltd. Ordinary Shares's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Entera Bio Ltd. Ordinary Shares's Net Income (TTM)?: Entera Bio Ltd. Ordinary Shares's Net Income (TTM) is -$17.0M, based on as-reported figures from SEC (XBRL) filings.
What is Entera Bio Ltd. Ordinary Shares's EBITDA?: Entera Bio Ltd. Ordinary Shares's EBITDA is -$14.4M, based on as-reported figures from SEC (XBRL) filings.
What is Entera Bio Ltd. Ordinary Shares's Diluted EPS (TTM)?: Entera Bio Ltd. Ordinary Shares's Diluted EPS (TTM) is -0.10, based on as-reported figures from SEC (XBRL) filings.
What is Entera Bio Ltd. Ordinary Shares's Net Debt?: Entera Bio Ltd. Ordinary Shares's Net Debt is -$11.3M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ENTXAs-filed SEC (XBRL) data